Clinical Trial Update: QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for QL1604 plus chemotherapy in advanced cervical cancer; study has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• QL1604

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Cervical Cancer | Phase 2, Phase 3 | Status: TERMINATED